Navigation Links
siPORT NeoFX Transfection Agent 1 ml from Ambion

ProductssiPORT NeoFX Transfection Agent 1 ml from Ambion
Company Ambion
Item siPORT NeoFX Transfection Agent 1 ml
Price $190.00
Description Gene silencing experiments often call for critical, but time-consuming optimization experiments. siPORT NeoFX Transfection Agent refines siRNA transfection protocols resulting in less optimization. siPORT NeoFXs lipid-based formulation can be used to efficiently transfect adherent cells as they are subcultured without increased cytotoxicity. From start to finish, successful gene silencing experiments can be completed in as early as 24 hours. This streamlined protocol can be adapted to a wide range of cells and experimental designs, including high-throughput applications.
Info AmbionAmbion
2130 Woodward
Austin, TX 78744
USA

Call Ambion to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-512-795-4221
Customer Service: 512-651-0200
Fax Number: 512-651-0201
Web Site: http://www.ambion.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. siPORT NeoFX Transfection Agent from Ambion
2. siPORTer™-96 Electroporation Chamber from Ambion
3. GenomONE-Neo EX HVJ-E 4 vial(s) Transfection Reagents from Cosmo Bio Co., Ltd.
4. Label IT siRNA Tracker CX-Rhodamine Intracellular Localization Kit with TransIT-TKO siRNA Transfection Reagent from Mirus Bio Corporation
5. Label IT siRNA Tracker Intracellular Localization Kit with TransIT-TKO Transfection Reagent (Cy5 Labeling Kit) from Mirus Bio Corporation
6. Label IT siRNA Tracker Fluorescein Intracellular Localization Kit with TransIT-TKO siRNA Transfection Reagent from Mirus Bio Corporation
7. Label IT siRNA Tracker Biotin Intracellular Localization Kit with TransIT-TKO siRNA Transfection Reagent from Mirus Bio Corporation
8. jetSI-ENDO-FluoR from Polyplus Transfection
9. TransIT-siQUEST Transfection Reagent from Mirus Bio Corporation
10. jetSI-ENDO from Polyplus Transfection
11. TransIT-siQUEST Transfection Reagent from Mirus Bio Corporation
RABBIT (BABY) COMPLEMENT LYOPHILISED from AbD Serotec
Rabbit Anti-Human ZO-1 Antibody, Unconjugated from Lab Vision
Mouse Anti-Human Myeloid Marker Monoclonal Antibody, Unconjugated, Clone BM-1 from Santa Cruz Biotechnology, Inc.
5x C'GATE STOCK STABILIZING REAGENT from AbD Serotec
Biology Products:
(Date:11/24/2009)...ands of years it has been prescribed by traditiona...rom headaches and stomach pain to fever and flu. ,... University have been able to scientifically prove... otherwise known as Brazilian mint. , Testing th...ed by researcher Graciela Rocha was able to show t...
(Date:11/24/2009)...s have crystallised a protein that may help gut ba...tein could be used by probiotic producers to ident...to people. , "Probiotics need to interact with ce...d if they attach to surfaces in the gut they are m...eir activity," says Dr Nathalie Juge from the Inst...
(Date:11/24/2009)...and the American College of Medical Toxicology (AC... publication of the Journal of Medical Toxicology...ng in March 2010. It was previously published by ...urnal of Medical Toxicology , an international, pe... science and practice of medical toxicology. The ...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2A sticky solution for identifying effective probiotics 2Springer and the American College of Medical Toxicology to work together 2Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis 52567 1Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis 52567 2Injection Reverses Heart Attack Damage 4771 1Injection Reverses Heart Attack Damage 4771 2Injection Reverses Heart Attack Damage 4771 3American Joint Replacement Registry Announced 52562 1American Joint Replacement Registry Announced 52562 2
...entified a key signaling molecule in the brain tha...g for cocaine. Their finding could offer an import...ircuiting that adaptive process. , In an article i...o Bonci and colleagues established that a short pr... region central to the adaptation to addictive dru...
...s shed more light on the multi-decade debate about...ng at them. , You don,t have to watch your legs an...are. For decades scientists have debated two optio...flow hypothesis says that the brain monitors signa...ly to contract, and uses this to predict where the...
...d "peak fish" and fishermen,s nets will be hauling...l action to stem the global tide of over fishing, ... British Columbia. Dr. Daniel Pauly says the crisi...c proof than about attitude and political will. ,...gh-profile political champion like a Bono or Mande...
Other Biology News:How the brain learns to become addicted 2How does the brain know what the right hand is doing? 2Hooked on fishing, and we're heading for the bottom, says scientist 2Hooked on fishing, and we're heading for the bottom, says scientist 3
(Date:11/24/2009)... The New York investment bank KTA Capital,s cli...d an AU$6.7 mil convertible note private placement...lacement was arranged by KTA Capital as Neuren,s e... New York (PRWEB) November 23, 2009 ...pital, LLC ("KTA Capital") has announced...
(Date:11/24/2009)...IS, Nov. 24 Sigma-Aldric...at the NASDAQ OMX conference on Tuesday, December ...rested parties may listen via live audio broadcast...tor.sig m a a ldrich.com/ . Users can click ...About Sigma-Aldrich: Sigma-Aldrich is a leading ...
(Date:11/24/2009)...TEO, Calif., Nov. 24 Neu... company focused on developing and commercializing...that Anthony DiTonno, President and Chief Executiv...ual Piper Jaffray Health Care Conference, to be he... in New York, New York. ,, Mr. DiTonno and Ste...
(Date:11/24/2009)...ary efficacy endpoint has been met for patients wi...cer, , QUEBEC CITY, Nov. 24 /PRNewswire-First...: AEZ) (the "Company"), a global biopharmaceutical..., today announced positive efficacy data from a Ph...njugate, AEZS-108 (formerly AN-152), in patients w...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4